Decera Clinical Education Oncology Podcast
Episodes
The Art of Medicine: Clinical Considerations for Patients With Advanced RCC
21 Sep 2020
Contributed by Lukas
In this episode, an expert medical oncology panel led by Elizabeth R. Plimack, MD, MS, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses c...
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1
17 Sep 2020
Contributed by Lukas
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer questions focused on the optimizing BTK inhibitor thera...
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3
17 Sep 2020
Contributed by Lukas
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from a live Webinar focused on optima...
Clinical Considerations for <em>RET</em> Fusion–Positive NSCLC
17 Sep 2020
Contributed by Lukas
In this podcast episode, listen to lung cancer experts Joshua Bauml, MD, a medical oncologist, and Dara L. Aisner, MD, PhD, a molecular pathologist, d...
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2
16 Sep 2020
Contributed by Lukas
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from a live Webinar focused on optim...
CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions
14 Sep 2020
Contributed by Lukas
In this episode, Michael R. Bishop, MD; Daniel J. DeAngelo, MD, PhD; and Noopur Raje, MD, answer clinician questions on current best practices and em...
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond
08 Sep 2020
Contributed by Lukas
In this episode, an expert medical oncology panel, led by Elizabeth R. Plimack, MD, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses curr...
FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma
03 Sep 2020
Contributed by Lukas
In this episode, Jesús F. San-Miguel, MD, PhD; Paula Rodriguez-Otero, MD, PhD; and Prof. Dr. med. Katja Weisel answer questions focused on current ...
New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments
01 Sep 2020
Contributed by Lukas
In this episode, Natalie S. Callander, MD, and Shaji Kumar, MD, answer audience questions from a live CCO Webinar on relapsed/refractory myeloma regar...
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy
31 Aug 2020
Contributed by Lukas
In this episode, Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for the first-line treatm...
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma
31 Aug 2020
Contributed by Lukas
In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in Waldenström macroglobulinemia, mantle c...
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1
28 Aug 2020
Contributed by Lukas
In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on MET exon 14 testing and sele...
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2
28 Aug 2020
Contributed by Lukas
In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on biomarking testing and the use ...
Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies
27 Aug 2020
Contributed by Lukas
In this episode, Anna F. Farago, MD, PhD, and Taofeek K. Owonikoko, MD, PhD, answer questions focused on the topic of current and evolving use of im...
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL
26 Aug 2020
Contributed by Lukas
In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in CLL presented at the 2020 annual meeting...
Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond
14 Aug 2020
Contributed by Lukas
In this episode, Naval G. Daver, MD, discusses promising investigational agents and treatment combinations in clinical trials for patients with newly ...
Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions
14 Aug 2020
Contributed by Lukas
In this episode, George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer questions about NTRK fusion testing and TRK inhibitor ther...
Improving Outcomes for Patients With CML With TKIs: FAQ Podcast
13 Aug 2020
Contributed by Lukas
In this episode, Prof. Dr. med Tim Henrik Brümmendorf; Jorge Cortes, MD; and Carlo Gambacorti-Passerini, MD, answer questions focused on the optimal...
Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies
10 Aug 2020
Contributed by Lukas
In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on biomarker testing and selecting targeted therap...
Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions
10 Aug 2020
Contributed by Lukas
In this episode, an expert medical oncology panel led by John L. Marshall, MD, with Jamie E. Chaft, MD, and Scot Niglio, MD, provides a brief overvie...
Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors
10 Aug 2020
Contributed by Lukas
In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on current and evolving biomarkers for immune chec...